Aug 10, 2026 · 6 min
Rocket Lab, Moderna and Intel test investor optimism
RocketLab Climbs; Moderna Flu Shot; Intel Stock Offering
The episode connects three company-specific catalysts with a larger question about whether AI-led growth can justify its infrastructure costs.
- 1Rocket Lab’s Space Force contract and upcoming earnings put renewed attention on its Neutron rocket prospects.
- 2Moderna shares rose after FDA approval of its seasonal mRNA influenza vaccine.
- 3Intel’s $15 billion stock offering supports a turnaround narrative while data-center growth raises water and electricity concerns.
Don't miss
The discussion links Intel’s AI and data-center opportunity to the water and electricity demands that smart cities must plan for.
The brief
Rocket Lab’s recent decline gives way to a closer look at upcoming earnings and a major U.S. Space Force contract tied to its Neutron rocket.
Moderna moves higher after FDA approval of its seasonal mRNA flu vaccine, adding a regulatory catalyst to the market’s daily company-by-company churn.
Intel’s planned $15 billion stock offering becomes a test of its turnaround story, as stronger AI and data-center prospects meet concerns about resource demands.
The episode then widens its lens: AI and rapid urbanization are reshaping smart-city planning, with Dubai presented as a case of long-term infrastructure ambition.
The central tension is clear: data-center growth may strengthen companies such as Intel while intensifying the water, electricity and planning challenges cities must manage.
What was said on this episode
11 statements · 10 positive · 1 negative
Rocket Lab shares fell 36% last month.
“It plunged 36% last month.”
Listen at 0:44
Rocket Lab shares rose about 1% pre-market.
“it's up about 1% in the pre-market.”
Listen at 0:48
Rocket Lab won a $397 million spacecraft contract from the U.S. Space Force.
“it just won a $397 million contract. to build and launch a spacecraft for the U.S. Space Force using its upcoming neutron rocket.”
Listen at 0:55
Private space companies and national space agencies are expected to launch more flatulites.
“more and more private space companies and national space agencies are expected to launch these satellites”
Listen at 1:16
FDA approval gives Moderna its first approved flu shot.
“This is a big regulatory win that gives the company its first approved flu shot.”
Listen at 1:47
Intel shares nearly tripled this year to about $101.
“Intel shares have nearly tripled in value so far this year to about $101”
Listen at 3:00
Data-center demand increased Intel’s CPU sales.
“data center demand has increased sales of its central processing units.”
Listen at 3:11
Intel’s data-center segment sales rose 59% last quarter.
“Sales in Intel's data center segment soared 59% last quarter”
Listen at 3:15
AI will compress smart-city processes and change their speed.
“AI will allow in the smart city space to compress a lot of things. The speed will change.”
Listen at 4:23
Dubai responded very well to its sudden population increase.
“they reacted very well to it.”
Listen at 4:49
Dubai has a long-term urban planning vision.
“They have a long-term urban planning vision”
Listen at 4:51
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Rocket Lab
Neutron
United States Space Command
Bloomberg L.P.Listen to the full episode and explore every guest, topic, and moment on PodLume.